Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Given Average Recommendation of “Moderate Buy” by Brokerages

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has received a consensus recommendation of “Moderate Buy” from the twelve ratings firms that are presently covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation, six have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $13.50.

A number of research analysts have commented on AVAH shares. Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $10.00 to $11.00 in a research note on Friday, May 15th. BMO Capital Markets boosted their target price on shares of Aveanna Healthcare from $10.00 to $14.00 and gave the stock an “outperform” rating in a research report on Friday, August 14th. Royal Bank Of Canada increased their price target on shares of Aveanna Healthcare from $10.00 to $16.00 and gave the stock an “outperform” rating in a research report on Monday, August 24th. Truist Financial lifted their price target on Aveanna Healthcare from $11.00 to $15.00 and gave the stock a “hold” rating in a research note on Monday, August 24th. Finally, Wall Street Zen lowered Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th.

Aveanna Healthcare Price Performance

Shares of NASDAQ AVAH opened at $13.58 on Monday. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 4.47. Aveanna Healthcare has a fifty-two week low of $5.93 and a fifty-two week high of $14.00. The business has a 50 day moving average price of $10.69 and a two-hundred day moving average price of $8.31. The firm has a market cap of $2.96 billion, a PE ratio of 11.04, a price-to-earnings-growth ratio of 0.85 and a beta of 1.97.

Aveanna Healthcare (NASDAQ:AVAH) last announced its earnings results on Thursday, August 13th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.05. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%.The company had revenue of $670.48 million for the quarter, compared to analyst estimates of $638.61 million. Sell-side analysts expect that Aveanna Healthcare will post 0.75 earnings per share for the current fiscal year.

Insider Transactions at Aveanna Healthcare

In other news, major shareholder J.H. Whitney Equity Partners V sold 12,496,077 shares of the business’s stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total value of $143,704,885.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Paul Vigano sold 14,500,002 shares of the company’s stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total value of $166,750,023.00. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 59,904,505 shares of company stock worth $649,301,514. 5.30% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of AVAH. Littlejohn & Co. LLC acquired a new stake in shares of Aveanna Healthcare during the 2nd quarter worth approximately $1,846,878. Vanguard Group Inc. boosted its position in Aveanna Healthcare by 38.0% during the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock valued at $45,564,000 after purchasing an additional 1,535,351 shares during the period. Parkman Healthcare Partners LLC acquired a new position in Aveanna Healthcare during the 2nd quarter valued at approximately $6,123,000. Segall Bryant & Hamill LLC grew its stake in Aveanna Healthcare by 425.8% during the 1st quarter. Segall Bryant & Hamill LLC now owns 163,966 shares of the company’s stock worth $1,056,000 after buying an additional 132,779 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in Aveanna Healthcare by 49.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,334,374 shares of the company’s stock worth $8,593,000 after buying an additional 441,707 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.